Table 3.
Comparison of prevalence of colorectal neoplasm between endoscopic submucosal dissection group and fecal immunochemical test group n (%)
| Colorectal neoplasm | ESD group (n = 158) | FIT group (n = 158) | P value |
| Adenoma (< 1 cm) | 53 (33.5) | 66 (41.8) | 0.164 |
| Advanced adenoma | 17 (10.8) | 24 (15.2) | 0.315 |
| Large tubular adenoma (≥ 1 cm) | |||
| Tubulovillous/villous adenoma | |||
| High grade dysplasia | |||
| Number of adenomas | 0.507 | ||
| 1 to 3 | 59 (37.3) | 71 (44.9) | |
| ≥ 4 | 11 (7.0) | 19 (12.0) | |
| Cancer or NET | 10 (6.3) | 10 (6.3) | 0.999 |
ESD: Endoscopic submucosal dissection; FIT: Fecal immunochemical test; NET: Neuroendocrine tumor.